Investment Summary |
|
|---|---|
| Date | 2010-01-01 |
| Target | Masterskill |
| Sector | Education |
| Sellers(s) |
Ethos Capital Sdn. Bhd.
Quilvest Capital Partners |
| Deal Type | IPO |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2007 |
| PE ASSETS | 68M USD |
| Size | Small |
| Type | Sector Agnostic |
Ethos Capital Sdn. Bhd. is a private equity firm focused on investing throughout Malaysia. The Firm will consider opportunities in a broad range of industries. Ethos focuses on growth businesses, with proven track records and strong management. Ethos Capital Sdn. Bhd. was formed in 2007 and is based in Kuala Lumpur.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Education M&A | 1 of 1 |
| Type: IPO M&A Deals | 1 of 1 |
| Country: Malaysia M&A | 1 of 1 |
| Year: 2010 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-09-04 |
Masterskill
Cheras, Malaysia Masterskill is a healthcare oriented university college. The Company provides education programs in nursing and allied health in Malaysia. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1972 |
| PE ASSETS | 7.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Quilvest Capital Partners is the private equity investment arm of asset management firm Quilvest. Quilvest Capital Partners invests in private equity and debt funds as well as makes direct investments. The direct investment group looks for opportunities in the US, Europe, and 'opportunistically' in Asia with a preference for buyout, growth capital, and venture transactions. Quilvest Capital Partners will consider both minority and majority positions. Quilvest Capital Partners was established in 1972 and is based Paris.
| DEAL STATS | # |
|---|---|
| Overall | 15 of 69 |
| Sector: Education M&A | 1 of 2 |
| Type: IPO M&A Deals | 2 of 7 |
| Country: Malaysia M&A | 1 of 1 |
| Year: 2010 M&A | 1 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-10-01 |
NeoTract
Pleasanton, California, United States NeoTract, Inc. is a privately-held medical device company that has developed and commercialized the FDA-cleared UroLift® System, a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia, or BPH. Performed primarily through a transurethral outpatient procedure, the UroLift® System delivers permanent implants that hold open the urethra, reducing the prostate obstruction without cutting, heating, or removing prostate tissue. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-03-01 |
Vanksen
Bertrange, Luxembourg Vanksen is a digital-native agency with expertise in social media, SEO, social data and e-reputation, strategic consulting, and digital implementation. Vanksen was founded in 2001 and is based in Bertrange, Luxembourg. |
Buy | - |
